Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-06-2014 | Review

Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case–control studies

Authors: Cuiping Li, Yang Zhou

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2014

Abstract

Purpose

Quinone oxidoreductase (NQO1) C609T polymorphisms have been implicated in acute lymphoblastic leukemia (ALL) risk, but previously published studies were inconsistent and recent meta-analyses were not adequate. The aim of this study was to determine more precise estimations for the relationship between the NQO1 C609T polymorphism and the risk of ALL.

Methods

Electronic searches for all publications were conducted on association between this variant and ALL in several databases updated in May 2013. The quality of studies was evaluated using the Newcastle-Ottawa Scale. Crude odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of the association. Seventeen studies were identified, including 2,264 ALL patients and 3,798 controls.

Results

Overall, significantly elevated ALL risk was associated with NQO1 C609T variant genotypes when all of the studies were pooled into the meta-analysis (TT vs. CC: OR 1.46, 95 % CI 1.18–1.79; dominant model: OR 1.45, 95 % CI 1.19–1.77). In the subgroup analysis by ethnicity, significantly increased risks were found for non-Asians (T/T vs. C/C: OR 1.74, 95 % CI 1.29–2.36; dominant model: T/T + C/T vs. C/C: OR 1.7, 95 % CI 1.27–2.29). When stratified by adult or children studies, statistically significantly elevated risks were found among adult studies (codominant model: C/T vs. C/C: OR 1.38, 95 % CI 1.02–1.87; dominant model: T/T + C/T vs. C/C: OR 1.52, 95 % CI 1.18–1.97) and children studies (recessive model: T/T vs. C/T + C/C: OR 1.34, 95 % CI 1.05–1.7).

Conclusions

Our results indicate that the C609T polymorphism of the NQO1 gene is an important genetic risk factor in ALL.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefPubMed

Belinsky M, Jaiswal AK (1993) NAD(P)H: quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12(2):103–117CrossRefPubMed

Bolufer P, Barragan E, Collado M, Cervera J, Lopez JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30(12):1471–1491. doi:10.1016/j.leukres.2006.01.016 CrossRefPubMed

Bolufer P, Collado M, Barragan E, Cervera J, Calasanz MJ, Colomer D, Roman-Gomez J, Sanz MA (2007) The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 92(3):308–314CrossRefPubMed

Canalle R, Burim RV, Tone LG, Takahashi CS (2004) Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 43(2):100–109. doi:10.1002/em.20003 CrossRefPubMed

Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE (2011) Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 29(3):116–123. doi:10.1002/hon.965 CrossRefPubMed

Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M (2006) NAD(P)H: quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(5):979–987. doi:10.1158/1055-9965.EPI-05-0899 CrossRefPubMed

Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L (1999) Association of the NAD(P)H: quinone oxidoreductase 609C– > T polymorphism with a decreased lung cancer risk. Cancer Res 59(13):3045–3048PubMed

Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, Park HJ, Kim SY (2006) Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci 21(6):1075–1079PubMedCentralCrossRefPubMed

Clavel J, Bellec S, Rebouissou S, Menegaux F, Feunteun J, Bonaiti-Pellie C, Baruchel A, Kebaili K, Lambilliotte A, Leverger G, Sommelet D, Lescoeur B, Beaune P, Hemon D, Loriot MA (2005) Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 14(6):531–540CrossRefPubMed

Cochran WG (1950) The comparison of percentages in matched samples. Biometrika 37(3–4):256–266CrossRefPubMed

de Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS, Emerenciano M, de Camargo B, Bernstain L, Neves CC, Agareno JM, de Carvalho LM, Araujo FN, de Brito NP, Magalhaes IQ, Cordoba JC, Pimenta F, Gadelha A, Cartaxo E, Basegio RM, Mnayarji A, Souza MS, Arencibia A, Melaragno R, Coser VM, Lafayete TC, Koifman S (2012) NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55 M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control 23(11):1811–1819. doi:10.1007/s10552-012-0060-5 CrossRefPubMed

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMedCentralCrossRefPubMed

Farhad Z, Safaei A, Nasiri N, Abdollahzadeh M, Pazhakh V (2012) The Association of NAD(P)H: quinine oxidoreductase gene polymorphisms with pediatric acute lymphoblastic leukemia. Science 43(6):256–261

Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA (2008) NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 168(11):1221–1232. doi:10.1093/aje/kwn246 PubMedCentralCrossRefPubMed

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557 PubMedCentralCrossRefPubMed

Infante-Rivard C, Vermunt JK, Weinberg CR (2007) Excess transmission of the NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am J Epidemiol 165(11):1248–1254. doi:10.1093/aje/kwm022 PubMedCentralCrossRefPubMed

Jia MF, Xi YM, Shi XE, Zhang H, Deng W, Li M, Li P, Xu JW, Ma HZ, Yao XJ (2012) Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(6):1336–1340PubMed

Kracht T, Schrappe M, Strehl S, Reiter A, Elsner HA, Trka J, Cario G, Viehmann S, Harbott J, Borkhardt A, Metzler M, Langer T, Repp R, Marschalek R, Welte K, Haas OA, Stanulla M (2004) NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 89(12):1492–1497PubMed

Krajinovic M, Labuda D, Sinnett D (2001) Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome. Rev Environ Health 16(4):263–279CrossRefPubMed

Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97(2):230–236CrossRefPubMed

Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72(3):555–561PubMedCentralCrossRefPubMed

Lanciotti M, Dufour C, Corral L, Di Michele P, Pigullo S, De Rossi G, Basso G, Leszl A, Luciani M, Lo Nigro L, Micalizzi C, Valsecchi MG, Biondi A, Haupt R (2005) Genetic polymorphism of NAD(P)H: quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 19(2):214–216. doi:10.1038/sj.leu.2403613 CrossRefPubMed

Larfors G, Hallbook H, Simonsson B (2012) Parental age, family size, and offspring’s risk of childhood and adult acute leukemia. Cancer Epidemiol Biomarkers Prev 21(7):1185–1190. doi:10.1158/1055-9965.EPI-12-0178 CrossRefPubMed

Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT (1999) Prevalence of the inactivating 609C– > T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 94(2):803–807PubMed

Li H, Hao X, Zhang W, Wei Q, Chen K (2008) The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(7):1739–1745. doi:10.1158/1055-9965.EPI-08-0001 CrossRefPubMed

MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault G (2008) Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 19(3):283–295. doi:10.1007/s10552-007-9091-8 CrossRefPubMed

Moran JL, Siegel D, Ross D (1999) A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A 96(14):8150–8155PubMedCentralCrossRefPubMed

Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG (2002) NAD(P)H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4(2):62–70. doi:http://www.indexscholar.com/?record=1207241 CrossRefPubMed

Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S (2013) Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population. Mol Biol Rep 40(2):1307–1314. doi:10.1007/s11033-012-2174-y CrossRefPubMed

Perera FP (1997) Environment and cancer: who are susceptible? Science 278(5340):1068–1073CrossRefPubMed

Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK (1998) Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273(13):7382–7389CrossRefPubMed

Rimando M, Yuson ED, de Castro-Bernas G, Okamoto T (2008) Prevalence of GSTT1, GSTM1 and NQO1(609C > T) in filipino children with ALL(acute lymphoblastic leukaemia). Biosci Rep 28(3):117–124CrossRefPubMed

Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA (2010) NAD(P)H: quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev 11(1):209–213PubMed

Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Drager BJ, Sies H (1997) Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 7(3):235–239CrossRefPubMed

Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18(11):2309–2315PubMed

Siegel D, Ryder J, Ross D (2001) NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol Lett 125(1–3):93–98CrossRefPubMed

Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG (2010) Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 51(1):48–56. doi:10.1002/em.20510 PubMed

Sirma S, Agaoglu L, Yildiz I, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U (2004) NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 43(5):568–570. doi:10.1002/pbc.20098 CrossRefPubMed

Smith MT (1999) Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci U S A 96(14):7624–7626PubMedCentralCrossRefPubMed

Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G (2001) Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood 97(5):1422–1426CrossRefPubMed

Spector TD, Thompson SG (1991) The potential and limitations of meta-analysis. J Epidemiol Community Health 45(2):89–92PubMedCentralCrossRefPubMed

Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482(1–2):21–26CrossRefPubMed

Strassburg A, Strassburg CP, Manns MP, Tukey RH (2002) Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH: quinone oxidoreductase in human hepatocellular and biliary tissue. Mol Pharmacol 61(2):320–325CrossRefPubMed

Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW (1992) NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52(4):797–802PubMed

Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8):1405–1414. doi:10.3324/haematol.2010.022095 PubMedCentralCrossRefPubMed

Yamaguti GG, Lourenco GJ, Silveira VS, Tone LG, Lopes LF, Lima CS (2010) Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)-inherited gene variants. Acta Haematol 124(3):182–184. doi:10.1159/000320275 CrossRefPubMed

Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, Quah TC (2010) Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 34(3):276–283. doi:10.1016/j.leukres.2009.07.003 CrossRefPubMed

Zhang ZQ, Yang L, Zhang Y, Yang YH, Nie L, Li L, Wang JX, Zhu XF, Xiao ZJ (2009) Relationship between NQO1C(609T), RAD51(G135C), XRCC3(C241T) single nucleotide polymorphisms and acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(3):523–528PubMed

Title: Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case–control studies
Authors: Cuiping Li
Yang Zhou
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: Journal of Cancer Research and Clinical Oncology / Issue 6/2014
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-014-1595-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case–control studies

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2014

The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre

Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells

Red meat consumption and stomach cancer risk: a meta-analysis

Primary malignant cardiac tumors

IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma

Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998–2010

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page